Filter by tags: South Korea United States Europe Clear all tag filters
31 news articles found
The Sino-French TAC-1 consortium - led by China National Nuclear Corporation subsidiary China Nuclear Power Engineering and including Framatome - has been awarded a contract to assemble the vacuum chamber modules of the International Thermonuclear Experimental Reactor (ITER), under construction in Cadarache, southern France.
- Source: World Nuclear News
- Date: Wednesday, 06 March 2024
- Original article: world-nuclear-news.org/Articles/Contract-for-ITER-vacuum-vessel-assembly
Dutch government has chosen Borssele site as preferred location for two new reactors
- Source: Nucnet
- Date: Friday, 23 February 2024
- Original article: nucnet.org/news/westinghouse-to-evaluate-ap1000-reactor-technology-for-ambitious-new-nuclear-programme-2-4-2024
Czech power utility CEZ Group's Elektrárna Dukovany II (EDU II), a wholly owned subsidiary has received three final bids for the construction of a new unit at the Dukovany NPP. US-based Westinghouse, France’s EDF and Korea Hydro & Nuclear Power (KHNP) submitted binding bids for Dukovany 5 and non-binding bids for the other three units. Westinghouse is proposing its AP1000, KHNP its APR1000 based in the APR1400 and EDF its EPR1200 (a smaller version of its standard EPR). These are all pressurised water reactors. Russia and China were excluded from the bidding in 2021.
- Source: NEI Magazine
- Date: Friday, 03 November 2023
- Original article: neimagazine.com/news/newsfinal-bids-submitted-for-new-dukovany-npp-units-11265668
ČEZ subsidiary Elektrárna Dukovany II (EDU II) has received final bids from the three potential suppliers for a new nuclear unit at Dukovany, as well as non-binding offers for three more future reactors.
- Source: World Nuclear News
- Date: Wednesday, 01 November 2023
- Original article: world-nuclear-news.org/Articles/Westinghouse,-EDF-and-KHNP-submit-final-Czech-bids
A Memorandum of Understanding (MOU) has been signed by Romanian nuclear utility Societatea Na?ionala Nuclearelectrica (SNN), US-based NuScale Power, Romanian companies E-INFRA and Nova Power & Gas, US-based Fluor Enterprises and South Korea’s Samsung C&T Corporation to collaborate in the deployment of NuScale VOYGR Power Plants in Central and Eastern Europe and in Romania.
- Source: NEI Magazine
- Date: Friday, 16 June 2023
- Original article: neimagazine.com/news/newscompanies-collaborate-to-promote-nuscale-smrs-in-central-and-eastern-europe-10943608
Nuclearelectrica, E-INFRA, Nova Power & Gas, Fluor Enterprises, Samsung C&T Corporation and NuScale Power have signed a memorandum of understanding (MoU) to collaborate to implement NuScale small modular reactor plants (SMR) in Romania and elsewhere in Central and Eastern Europe.
- Source: World Nuclear News
- Date: Thursday, 15 June 2023
- Original article: world-nuclear-news.org/Articles/Nuclearelectrica-and-partners-sign-MoU-for-NuScale
"A new clean energy economy is emerging - and emerging much faster than many realise," International Energy Agency (IEA) Executive Director Fatih Birol said at the launch of the agency's eighth World Energy Investment report.
- Source: NEI Magazine
- Date: Wednesday, 31 May 2023
- Original article: neimagazine.com/news/newsiea-report-on-clean-energy-investments-says-little-about-nuclear-10897991
US-based NuScale Power has joined the Romanian Atomic Forum (Romatom) as a supporting member to champion the association’s nuclear energy goals. Romania aims to be the first country in Europe to deploy a NuScale VOYGR small modular reactor (SMR) power plant. John Hopkins, NuScale President & CEO, said NuScale was “committed to advancing the secure deployment of SMRs globally”.
- Source: NEI Magazine
- Date: Friday, 26 May 2023
- Original article: neimagazine.com/news/newsnuscale-power-joins-romanian-atomic-forum-10884712
Funding of up to USD275 million to advance the deployment of a NuScale Power Corporation VOYGR small modular reactor (SMR) plant in Romania was announced at the G7 leaders' summit by the USA and "multinational public-private partners" from Japan, South Korea and the United Arab Emirates.
- Source: World Nuclear News
- Date: Tuesday, 23 May 2023
- Original article: world-nuclear-news.org/Articles/NuScale-s-Romanian-SMR-plan-gets-USD275-million-bo
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023